• About us
• Contact

Advertisement

Product › Details

CB1 receptor antagonist

	Next higher product group	obesity drug
	Status	2010-02-04 development p1 existent
	Organisation	7TM Pharma A/S
	Group	7TM Pharma (Group)

Record changed: 2023-07-10

Advertisement

More documents for obesity drug

• [1] Antag Therapeutics. (12/4/24). "Press Release: Antag Therapeutics Announces €80 Million Series A Financing". Copenhagen....
• [2] Versant Ventures. (11/21/24). "Press Release: Versant Ventures Unveils Pep2Tango Therapeutics Inc.". Potomac, MD....
• [3] Haya Therapeutics SA. (9/4/24). "Press Release: Haya Therapeutics Announces Collaboration with Lilly to Discover Novel Regulatory Genome Targets for Obesity and Related Metabolic Conditions Using Proprietary RNA Platform". Lausanne & San Diego, CA....
• [4] SixPeaks Bio AG. (5/22/24). "Press Release: SixPeaks Bio AG Debuts With $110 Million in Funding". Basel....
• [5] AstraZeneca plc. (11/9/23). "Press Release: AstraZeneca Licenses Novel Agent for the Treatment of Cardiometabolic Conditions and Obesity [This press release is intended for investors and business / science media]"....
• [6] Embark Laboratories ApS. (8/30/23). "Press Release: Novo Nordisk Acquires Embark Biotech, including Its Lead Asset Targeting Obesity and other Cardiometabolic Diseases". Copenhagen....
• [7] Novo Nordisk A/S. (8/10/23). "Press Release: Novo Nordisk to Acquire Inversago Pharma to Develop New Therapies for People Living with Obesity, Diabetes and other Serious Metabolic Diseases". Bagsværd & Montreal....
• [8] Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases". Torino....
• [9] Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Raises €10 Million Series A to Complete First Clinical Trial for RES-010 in Obesity". Torino....
• [10] Inversago Pharma Inc.. (10/19/22). "Press Release: Inversago Pharma Announces Appointment of Ed Mathers, BSc and Nanna Lüneborg, PhD, MBA to its Board of Directors". Montréal, QC....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.